Yu‐Hang Yan

X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells

Lingling Yang, Huali Wang, Lei Zhong et al. · European Journal of Medicinal Chemistry · 2018 · 56 citations · Full text

Drug Target, Exhibit Activities, Medicine +10

Structure-Based Development of (1-(3′-Mercaptopropanamido)methyl)boronic Acid Derived Broad-Spectrum, Dual-Action Inhibitors of Metallo- and Serine-β-lactamases

Yaolin Wang, Sha Liu, Zhujun Yu et al. · Journal of Medicinal Chemistry · 2019 · 55 citations

Pharmacotherapy, Antimicrobial Chemotherapy, Chemical Biology +20

Light-mediated anthocyanin biosynthesis in rose petals involves a balanced regulatory module comprising transcription factors RhHY5, RhMYB114a, and RhMYB3b

Yu‐Hang Yan, Jiaxing Zhao, Shengnan Lin et al. · Journal of Experimental Botany · 2023 · 45 citations

AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases

Qing-Qing Dai, Yu‐Hang Yan, Xiang-Li Ning et al. · Acta Pharmaceutica Sinica B · 2021 · 35 citations · Full text

MeLAD: an integrated resource for metalloenzyme-ligand associations

Gen Li, Yu Su, Yu‐Hang Yan et al. · Bioinformatics · 2019 · 30 citations · Full text